In early 2018, the Company approved steps t

Quote:

---

In early 2018, the Company approved steps to focus its efforts on clinical trials for its lead drug candidates. The Company’s office and laboratory needs haveshifted from compound discovery to clinical development programs. The Company is now in the process of searching sites for its future headquarters.

---

This is all I saw. Can you point me to where they leased a new space?

It's certainly a positive development that they're planning as it's probably indicative of a coming deal. As we saw it took 8,000,000 shares (and a 30% decline in the stock price) to raise $2,000,000 so we're certainly not going it alone. Add it all up and we're probably getting some kind of deal.